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Abstract
Background: Disease prevalence and response to medical therapy may differ among patients of diverse ethnicities. Poor
outcomes with in vitro fertilization (IVF) treatment have been previously shown in Indian women compared to Caucasian
women, and some evidence suggests that poor embryo quality may be a cause for the discrepancy. In our center, only
patients with the highest quality cleavage stage embryos are considered eligible for extending embryo culture to the
blastocyst stage. We compared live birth rates (LBR) between Indian and Caucasian women after blastocyst transfer to
investigate whether differences in IVF outcomes between these ethnicities would persist in patients who transferred similar
quality embryos.
Methodology/Principal Findings: In this retrospective cohort analysis, we compared IVF outcome between 145 Caucasians
and 80 Indians who had a blastocyst transfer between January 1, 2005 and June 31, 2007 in our university center. Indians
were younger than Caucasians by 2.7 years (34.03 vs. 36.71, P=0.03), were more likely to have an agonist down regulation
protocol (68% vs. 43%, P,0.01), and were more likely to have polycystic ovarian syndrome (PCOS), although not significant,
(24% vs. 14%, P=0.06). Sixty eight percent of Indian patients had the highest quality embryos (4AB blastocyst or better)
transferred compared to 71% of the Caucasians (P=0.2). LBR was significantly lower in the Indians compared to the
Caucasians (24% vs. 41%, P,0.01) with an odds ratio of 0.63, (95%CI 0.46–0.86). Controlling for age, stimulation protocol
and PCOS showed persistently lower LBR with an adjusted odds ratio of 0.56, (95%CI 0.40–0.79) in the multivariate analysis.
Conclusions/Significance: Despite younger age and similar embryo quality, Indians had a significantly lower LBR than
Caucasians. In this preliminary study, poor prognosis after IVF for Indian ethnicity persisted despite limiting analysis to
patients with high quality embryos transferred. Further investigation into explanations for ethnic differences in
reproduction is needed.
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Introduction
The epidemiology of disease and response to medical therapy
can differ between ethnicities. Several disease processes have been
shown to differ between patients of Indian ethnicity compared to
Caucasian ethnicity. For example, populations from a South Asian
Indian background have a markedly higher risk for and mortality
from cardiovascular disease compared to Caucasian populations
[1,2]. Research in women’s health has shown a higher rate of
insulin resistance and incidence of polycystic ovarian syndrome
(PCOS) in Indian women compared to Caucasian women [3].
Ethnic differences in fertility and IVF outcome have also been
identified. Some European studies have found worse prognosis for
women of Indian ethnicity compared to women of Caucasian
ethnicity [4–7]. The cause behind the poor prognosis after
treatment with IVF in Indians compared to Caucasians remains
unclear. Two of the studies suggested that poor embryo quality in
Indian patients may account for the lower pregnancy rates in this
population [5,6].
We investigated whether IVF prognosis between Indian and
Caucasian ethnicities would differ in patients who transferred the
highest quality embryos. The standard day of embryo transfer in
our center is day 3 after oocyte retrieval; however, we consider
extending the embryo culture two more days to the blastocyst
stage if the embryo cohort has three or more excellent quality
embryos on day 3. The extended culture allows for better embryo
selection and fewer embryos to be transferred on day 5 after
oocyte retrieval, but has a small risk of have no further cleavage
and no embryo transfer.
We compared LBR in patients of Indian and Caucasian
ethnicity after blastocyst transfer in order to investigate whether
the differences in IVF outcome reported in these populations in
previous studies would persist in patients with similar high quality
embryos transferred.
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A total of 225 patients met inclusion criteria, 64% Caucasian
and 36% Indian. The Indian patients were younger than the
Caucasian patients by a mean of 2.7 years (P=0.03). Otherwise,
the patients were similar in patient characteristics such as CD3
FSH, BMI, obstetric history, number of previous IVF cycles, and
diagnoses for IVF (Table 1). A higher percentage (24%) of Indian
patients had PCOS compared to Caucasian patients (14%),
however this difference did not reach statistical significance
(P=0.06).
The details of the IVF cycles of each group are compared in
Table 2. A higher percentage of Indian patients had the long
protocol and a higher percentage of Caucasian patients had an
antagonist protocol. This difference is most likely explained by the
difference in average age of the two groups since our clinic
typically uses the antagonist protocol in older patients with a
higher chance of having a poor response to ovarian stimulation.
The two groups had a similar mean total dose of gonadotropins:
3714 IU for Caucasian patients and 3106 IU for Indian patients
(P=0.2). Other aspects of the IVF cycles were similar between the
two groups including mean endometrial thickness, total number of
oocytes retrieved, percentage of patients using ICSI, fertilization
rate, mean number of 2PN embryos, mean number of 8 cell
embryos, and mean number of blastocysts.
The two groups had a similar number of embryos transferred,
2.0 in Caucasians and 1.9 in Indians (P=0.6). The quality of
embryos was similar between the two groups. The percentage of
Table 1. Patient Characteristics.
Variable Caucasian Indian P-value
N=145 N=80
Woman’s Age 36.7163.90 (25.94–45.95) 34.0364.09 (25.73–41.71) 0.03
Body Mass Index 24.464.6 (17.5–40.1) 25.263.7 (16.8–35.6) 0.2
Nulligravid 43% 48% 0.3
Nulliparous 77% 76% 0.3
Prior spontaneous abortion 37% 36% 0.2
Cycle Day 3 FSHˆ 6.562.0 (2.1–13.9) 6.261.8 (2.5–11.7) 0.4
Number of Previous Cycles (%) 1.161.3 0.860.8 0.2
Diminished Ovarian Reserve 10% 6% 0.09
Male Factor 36% 38% 0.2
Endometriosis 11% 15% 0.1
PCOS* 14% 24% 0.06
Tubal factor 9% 10% 0.2
Unexplained Infertility 18% 16% 0.1
ˆFSH=follicle stimulating hormone *PCOS=polycystic ovarian syndrome.
doi:10.1371/journal.pone.0007599.t001
Table 2. Cycle Characteristics and Response.
Variable Caucasian Indian P-value
N=145 N=80
Antagonist Stimulation Protocol 48% 30% ,0.01
Long Luteal Lupron Stimulation Protocol 43% 68% ,0.01
Microdose Flare Stimulation Protocol 9% 2% 0.09
Total Dose of Gonadotropins (IU) 371461550 310661383 0.2
Endometrial Lining 10.361.7 (6.5–15.0) 9.961.8 (7.0–15.3) 0.1
Oocytes Retrieved 16.865.9 17.165.9 0.6
ICSI* 44% 43% 0.9
Fertilization Rate 69% 67% 0.7
Number of 8 Cells on Day 3 6.062.8 5.862.4 0.8
Number of Blastocysts 5.262.9 5.663.2 0.6
Embryos Transferred 2.060.7 1.960.7 0.6
Embryos transferred 4AB quality or higher 68% 71% 0.2
Number of Blastocysts Frozen 2.662.7 3.163.1 0.2
*ICSI=intracytoplasmic sperm injection.
doi:10.1371/journal.pone.0007599.t002
Ethnicity and IVF Outcome
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68% in the Caucasian patients and 71% in the Indian patients
(P=0.2). Our center only freezes blastocysts of 3BB quality or
better and the mean number of frozen blastocysts was similar
between the two groups: 2.6 for Caucasian patients and 3.1 for
Indian patients (P=0.5).
IVF cycle outcomes are reviewed in Table 3. Implantation rate
was higher in the Caucasian group, although this did not reach
statistical significance (39% vs. 28%, P=0.06). The rate of positive
pregnancy test was similar between the two groups (61% vs. 53%,
P=0.2). Indian patients had a significantly lower clinical
pregnancy rate compared to the Caucasian patients (36% vs.
52%, P=0.02). LBR was significantly lower in the Indian patients
compared to the Caucasian patients (24% vs. 41%, P,0.01) with
an odds ratio of 0.63, (95%CI 0.46–0.86). Multiple pregnancy rate
was similar between the two groups. In the Caucasian patients, 17
patients delivered multiples (12%), 16 sets of twins and one triplet
pregnancy. In the Indian patients, 7 patients delivered twins (9%)
and no triplets were delivered.
Controlling for age, stimulation protocol and diagnosis of
PCOS showed persistently lower LBR with an adjusted odds ratio
of 0.56, (95%CI 0.40–0.79) in the multivariate analysis. A
diagnosis of PCOS was included in the multivariate analysis
because the difference between the two groups approached
statistical significance (P=0.06) and PCOS in Indian women
appears to be clinically significant in regards to fertility (see
Discussion). Thus, differences seen in these variables between the
two ethnicities do not account for the lower clinical pregnancy rate
and LBR seen between the two groups.
Discussion
This cohort comparison of IVF outcome after blastocyst transfer
in women of different ethnicities found a significantly lower
pregnancy rate and LBR in Indian women compared to
Caucasian women during the same time period in our program.
This worse prognosis was seen despite the fact that the Indian
women were younger in age, had a similar response to ovarian
stimulation, and had similar embryo quality compared to the
Caucasian women.
Previous studies have shown worse prognosis for Indian women
compared to Caucasian women after IVF treatment. Mahmud et al.
found higher cycle cancellation rates and lower LBR in 44 Indian
women compared to 88 Caucasian women matched for age and
BMI despite similar doses of medication and number of oocytes
retrieved[6].Lashen etal.foundalowerimplantationrate(13%and
17%) and clinical pregnancy rate (16% and 23%) in 108 Indian
women compared to 216 Caucasian women after IVF [5]. Although
this difference did not reachstatistical significance, this study did find
a higher incidence of polycystic appearing ovaries in the Indian
group.
Several theories exist regarding the possible cause for subfertility
in the Indian population compared to Caucasians seen in these
studies. One common theory is a higher incidence of PCOS in
Indian women. Several studies recognize a higher incidence of
PCOS in Indian women compared to other ethnicities [3,8,9].
PCOS is a complex, multifaceted metabolic disorder associated
with insulin resistance, hyperandrogenism, and ovulation dysfunc-
tion leading to subfertility. Women of Indian ethnicity seem to be
more sensitive to the metabolic effects of this disorder and Rodin
et al. showed increased insulin resistance in Indian women
compared to Caucasian women at a similar BMI [3]. Palep-Singh
et al. found that Caucasian patients with PCOS had a 2.5 times
(95% CI: 1.25–5) higher chance of an ongoing clinical pregnancy
per cycle compared to their Indian counterparts [10]. In our study,
a higher percentage of Indian women had PCOS compared to the
Caucasian group (24% vs. 14%), however this difference did not
reach statistical significance (P=0.06).
Some research suggests that a high incidence of genital
tuberculosis (TB) in the Indian population may explain subfertility
in that population [11]. In a study of 300 women in Bombay,
India, being evaluated for tubal factor as a cause of infertility, 39%
were found to have genital TB diagnosed by endometrial biopsy,
serologic testing, or pathology from laparoscopic specimens. Dam
et al. suggest that treatment for latent TB should be considered in
Indian patients presenting with unexplained infertility and
repeated IVF failure [12]. None of the patients in our study had
been evaluated for genital TB by serologic testing or tissue culture,
however, none of the patients had uterine scarring based on
evaluation by hysteroscopy or hysterosalpigogram. Physicians
treating infertile women who have lived in TB endemic areas may
consider its evaluation under certain circumstances.
Some evidence suggests differences in rates of endometriosis
associated infertility among different ethnicities [13–14]. Miya-
zawa first noted ethnicity as a risk factor for endometriosis when
he noted a higher incidence of the disease in Japanese women
compared to Caucasians [15]. Arumgam et al. found a higher
incidence of endometriosis in patients from Malaysia undergoing
diagnostic laparoscopy for infertility compared to Caucasian
women in the United Kingdom undergoing the same procedure
[16]. Clinical teaching suggests a higher incidence of endometri-
osis in Indian women compared to Caucasian women, however, a
thorough literature review found no evidence of this association.
Endometriosis as an indication for in vitro fertilization did not
differ in Indians and Caucasians in our study (Table 1).
Our study has some limitations. We state that the groups had
similar embryo quality based on current standards of embryo
evaluation: visualization of cell number, degree of fragmentation.
Assessing embryo quality in this manner does not account for
genetic and epigenetic differences in embryos that may be
associated with IVF outcome. In addition, we only have ethnic
information on the female patient and we do not know the country
of birth or the length of time living in the U.S. Future studies
evaluating ethnicity and fertility should include male partner
ethnicity and more detailed information on time in U.S. since
environmental exposure may play a key role in fertility and
prognosis for treatment.
To our knowledge this is the largest comparison of IVF outcome
between Indian and Caucasian patients to date, and the only study
to include live birth rate after blastocyst transfer as the primary
outcome. It is striking that prognosis of live birth is lower in Indian
Table 3. Outcomes.
Variable Caucasian Indian P-value
N=145 N=80
Implantation Rate 39% 28% 0.06
Positive HCG * 61% 53% 0.2
Clinical Pregnancy* 52% 36% 0.02
SABˆ 22% 31% 0.4
Live Birth Rate* 41% 24% 0.003
Multiple Pregnancy* 12% 9% 0.5
*per embryo transfer.
ˆper clinical pregnancy.
doi:10.1371/journal.pone.0007599.t003
Ethnicity and IVF Outcome
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quality compared to the Caucasian population.
Our findings are very interesting but preliminary and we are
hesitant to suggest an explanation for the worse prognosis of
Indian women to Caucasian after treatment with IVF. Although
we attempt to control for embryo quality by only comparing
patients with a blastocyst transfer, we are limited by the current
assessment of embryo quality. Future investigations may reveal
molecular differences between embryos from women of different
ethnicities. A difference in implantation environment in Indian
women, due to PCOS, tuberculosis, and endometriosis, has been
suggested in previous studies, but our patients were not universally
screened for these conditions. Of the patients who were known to
have PCOS or endometriosis in our population, the incidence of
these conditions did not differ between the two ethnicities.
Future epidemiologic studies on ethnicity in IVF outcome
should be prospective and include more information on male
ethnicity, exposure to tuberculosis, thorough evaluation for PCOS,
place of birth and length of time living in different countries.
Further work should include investigation of metabolic, endocrine,
and immunologic differences between ethnicities which may guide
future treatment options of subfertility.
Materials and Methods
We conducted a retrospective review of all fresh, non-donor
IVF cycles resulting in blastocyst transfers from January 1, 2005, to
June 31, 2007, in our university IVF center. A questionnaire,
completed by all patients before their first visit to our clinic,
included a write-in response for ethnicity. Patients who answered
Caucasian or white in this section were included as Caucasian
ethnicity and patients who wrote in Indian were considered Indian
ethnicity for the purposes of this study. Any blastocyst transfers
with preimplantation genetic diagnosis were excluded. If patients
had multiple IVF cycles resulting in blastocyst transfer during this
time period, only the first cycle was included.
Institutional review board approval from Stanford University’s
Administrative Panels on Human Subjects in Medical Research
was obtained to conduct this study. Data was gathered
anonymously so individual patient consent was not obtained.
The intuitional review board approved the waiver of consent for
this study.
Patients received one of three standard ovarian stimulation
protocols: microdose lupron (flare), antagonist, or luteal down
regulation (long). Details of these protocols have been described
previously [17]. Younger, good prognosis patients typically will
follow the luteal down regulation protocol and older patients or
those with poor prognosis will follow either the microdose lupron
or antagonist protocols. Ultrasound monitoring of follicular
growth was performed after four days of gonadotropin stimulation
and approximately every other day as indicated. A dose of 10,000
units of human chorionic gonadotropin (hCG) was administered
when at least one follicle reached an average diameter of 17 mm
or greater. Oocyte retrieval was performed by transvaginal
ultrasound guidance 35 hours after hCG administration.
Fertilization of the oocytes was achieved with standard
insemination or intracytoplasmic sperm injection (ICSI) depending
on semen parameters or history of low fertilization. The oocytes
were examined for fertilization status 16–18 hours after IVF or
ICSI. The zygotes with two pronuclei were cultured for
24–48 hours in Sage Cleavage Medium (Cooper Surgical, Inc,
Trumbull, CT) with 10% Serum Protein Substitute (SPS, Irvine
Scientific, Santa Ana, CA).
A single team of experienced embryologists evaluated the
embryos on day 3 after oocyte retrieval, 68 to 72 hours after
oocyte harvest. Embryos were examined for cleavage (cell number)
and grade, which includes cytoplastmic fragmentation. Embryos
were graded as follows on day 3: Grade 1, blastomeres have equal
size and no cytoplasmic fragmentation; Grade 2, blastomeres have
equal size and minor cytoplasmic fragmentation involving ,10%
of the embryo; Grade 3, blastomeres have unequal size and
fragmentation involving 10–20% of the embryo; Grade 4,
blastomeres have equal or unequal size, and moderate to
significant cytoplasmic fragmentation covering 20–50% of the
embryo; and Grade 5, few blastomeres and severe fragmentation
covering $50% of the embryo [18].
If the embryo cohort had 3 or more 8 cell embryos grade 1 or 2
on day 3 after oocyte retrieval, then embryos were cultured to the
blastocyst stage in Blastocyst Medium (Irvine Scientific, Santa
Ana, CA) with 10% serum substitute supplement. Blastocysts were
classified with the grading system described previously [19]. We
defined good quality blastocysts based on a study by della Ragione
et al. showing that 4AA, 4AB, or better blastocysts have better
implantation potential and pregnancy outcome compared to
poorer quality blastocysts after a single embryo transfer [20]. Any
expanding, expanded, and hatching blastocysts with good inner
cell mass and trophectoderm epithelium (3BB or better) were
frozen on day 5 or day 6 with protocols described elsewhere [21].
Embryos which either arrested or were of worse quality than 3BB
were discarded or donated to research.
Transabdominal ultrasound-guided embryo transfer on day 5 or
6 after oocyte retrieval was performed using a Tefcat or Echotip
Softpass catheter (Cook Ob/GYN, Spencer, IN). All patients
received progesterone supplementation with vaginal suppositories
(200 mg three times a day) starting on the evening after oocyte
retrieval.
Data collected included patient characteristics: age, obstetric
history, body mass index (BMI), cycle day 3 FSH, number of
previous IVF cycles, and indication for IVF. PCOS was defined by
the Rotterdam criteria [22]. Data collected on IVF cycles collected
included ovarian stimulation protocol, amount of gonadotropins
used, endometrial lining thickness, number of oocytes retrieved,
fertilization method, fertilization rate, number of 8 cell embryos on
Day 3, number of blastocysts, number of embryos transferred, and
number of blastocysts frozen. The primary outcome measured was
LBR and secondary outcomes included were implantation rate,
positive pregnancy test, clinical pregnancy, spontaneous pregnan-
cy loss, and multiple pregnancy rate.
Implantation rate was defined as number of gestational sacs
seen on transvaginal ultrasound at 6 weeks gestation per number
of embryos transferred. A pregnancy test was considered positive if
the beta-hCG level was .5 mIU/mL 10–11 days after embryo
transfer. Clinical pregnancy was defined as gestational sac seen on
transvaginal sonogram at 6–7 weeks gestational age. Spontaneous
pregnancy loss was defined as loss of pregnancy after gestational
sac seen on transvaginal ultrasound at 6 weeks gestation. Live birth
data were collected by contacting patients with a 100% follow up
rate.
Continuous variables were examined for normality; if normally
distributed, compared with a Student’s t test, and if not normally
distributed, compared with a nonparametric test. Dichotomous
variables were compared with a chi squared test. All statistical tests
were two-tailed and used an alpha of 0.05. Univaritate analyses
were performed to determine baseline characteristic and cycle
parameter differences between the Indian population and the
Caucasian population. To estimate the independent contribution
of Indian ethnicity on treatment outcomes, a multivariable logistic
Ethnicity and IVF Outcome
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be statistically significant in univariate analyses (Tables 1 and 2)
and others generally regarded as clinically significant were
included in the model. The final model included age, diagnosis
of PCOS and protocol. Data were analyzed using STATA, version
9.0 (College Station, TX), and SAS, version 8.02 (Cary, NC).
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